Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v1-EN
Language French English
Date Updated 2017-04-24 2017-03-11
Drug Identification Number 02387646 02387646
Brand name APO-IRBESARTAN/HCTZ APO-IRBESARTAN/HCTZ
Common or Proper name IRBESARTAN/HCTZ IRBESARTAN/HCTZ
Company Name APOTEX INC APOTEX INC
Ingredients HYDROCHLOROTHIAZIDE IRBESARTAN HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 150MG 12.5MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 BTL 500 BTL
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01 2014-10-01
Estimated end date 2017-04-30 2017-04-30
Actual end date 2017-04-21
Shortage status Resolved Actual shortage
Company comments APO-IRBESARTAN/HCTZ FCT 150/12.5MG100BTL is available
Health Canada comments